Adjuvant doxycycline to enhance anti-amyloid effects: Results from the dual phase 2 trial

Although, doxycycline use is associated with improved outcomes in amyloidosis in retrospective studies, evidence from clinical trials is limited.This …

Read the full article here

Related Articles